#1 All Natural Blood Pressure Medicine
Powered by MaxBlogPress  

Posts Tagged ‘Drug’


 Powered by Max Banner Ads 


This video contains additional comments by Larry Hobbs related to the excerpt from Dr. Moore. This is an excerpt from a letter by Richard Moore, MD, PhD dated August 31, 2009. Dr. Moore’s received his MD from Indiana University, and his Ph.D. in biophysics from Purdue University. Starting in 1963, Dr. Moore spent 40 years as a college professor and research scientist teaching and researching cellular biophysics. Dr. Moore’s research group research group discovered that insulin regulates the activity of the mechanism that exchanges potassium for sodium in live cells. Dr. Moore’s group also also discovered that, connected with this, insulin elevates the pH inside cells. This research and that of others then led to insights in how our dietary imbalance between potassium and sodium cause hypertension and other diseases. “Since recognizing the critical importance of the dietary ratio of potassium-to-sodium (in 1983), I have been trying to educate the public about this issue primarily by writing books.” Dr. Moore is the author of several books including “The High Blood Pressure Solution”. Dr. Moore is the also co-author of “The Salt Solution”. This book discusses how an imbalance of potassium and sodium not only affects: stroke hypertension but also how it affects: osteoporosis stomach cancer asthma kidney disease “During the summer of 1956, between my junior and senior year in medical school, I was fortunate to work in the research laboratories of Eli Lilly.” “It was a


Official Site: www.LowBPdrugFree.com – The Secret to Natural Blood Pressure Control. 10 Dirty Secrets About the Blood Pressure Drug Industry. Plus, learn about The Breathtaking Nature Method, a clinically proven, drug-free way to control hypertension on our channel LowBPdrugFree, and at: LowerBloodPressureDrugFree.com.

Relevant Resources


UCSF’s Osher Lifelong Learning Institute presents this series exploring the latest science about the treatment and managment of Cardiovascular disease. Join William Grossman, MD., Chief, Division of Cardiology, UCSF for a look at the use of drug therapy in the treatment of Atherosclerotic Heart and Vascular Disease. Series: “UCSF Mini Medical School for the Public” [2/2006] [Health and Medicine] [Professional Medical Education] [Show ID: 11317]


This is an excerpt from a letter by Richard Moore, MD, PhD dated August 31, 2009. Dr. Moore’s received his MD from Indiana University, and his Ph.D. in biophysics from Purdue University. Starting in 1963, Dr. Moore spent 40 years as a college professor and research scientist teaching and researching cellular biophysics. Dr. Moore’s research group research group discovered that insulin regulates the activity of the mechanism that exchanges potassium for sodium in live cells. Dr. Moore’s group also also discovered that, connected with this, insulin elevates the pH inside cells. This research and that of others then led to insights in how our dietary imbalance between potassium and sodium cause hypertension and other diseases. “Since recognizing the critical importance of the dietary ratio of potassium-to-sodium (in 1983), I have been trying to educate the public about this issue primarily by writing books.” Dr. Moore is the author of several books including “The High Blood Pressure Solution”. Dr. Moore is the also co-author of “The Salt Solution”. This book discusses how an imbalance of potassium and sodium not only affects: stroke hypertension but also how it affects: osteoporosis stomach cancer asthma kidney disease “During the summer of 1956, between my junior and senior year in medical school, I was fortunate to work in the research laboratories of Eli Lilly.” “It was a wonderful experience.” “All of the scientists there were first rate and dedicated to finding the

Relevant Resources

Quark Pharmaceuticals Announces Presentations of its Two siRNA Drug Candidates at Glaucoma & Retinopathies 2010
Quark Pharmaceuticals, Inc., a world leader in the discovery and development of RNAi-based therapeutics, today announced that two of its siRNA drug candidates were featured in the following two presentations at the Glaucoma & Retinopathies 2010 conference, which was held June 21-22, 2010 in London, UK:

Read more on PR Newswire via Yahoo! Finance


Relevant Resources

Record Users, Replay Movies, See Heatmaps of Website Behavior

Powered by Yahoo! Answers